INSULET CORP (Surgical & Medical Instruments & Apparatus)
Surgical & Medical Instruments & Apparatus
Filing Clarity monitors every SEC filing for INSULET CORP — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.
Recent SEC filing signals
Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.
Earnings SynthesisINSULET CORP Q1-2025: "intersection of Consumer Health and MedTech" First appearance; introduced by new CEO Ashley Mc…2026-08-17
Earnings SynthesisINSULET CORP Q2-2025: "first mover in type 2" Increased frequency; now positioned as core growth pillar2026-08-17
Earnings SynthesisINSULET CORP Q2-2026: "strong double-digit growth" increased frequency in describing international markets2026-08-17
Earnings SynthesisINSULET CORP Q3-2025: "manufacturing expansion" increased frequency from Q2-20252026-08-17
Earnings SynthesisINSULET CORP Q4-2025: "2026 guidance" First appearance since guidance was deferred from Q3-2025; dominant theme of th…2026-08-17
Earnings SynthesisINSULET CORP Q1-2026: "approximately 20%" first appearance as specific margin guidance target2026-08-17
Ecosystem
Monitor PODD with Filing Clarity
Plain-English signals for every PODD SEC filing. Free during our testing period — no credit card required.
Add PODD to my watchlist →